NORAMCO INC

Overview

NORAMCO INC is an active pharmaceutical ingredient (API) supplier with 27 active FDA Type II Drug Master Files, covering BUPRENORPHINE; BUPRENORPHINE BASE (R371605) DRUG SUBSTANCE; BUPRENORPHINE HYDROCHLORIDE (R036869) DRUG SUBSTANCE; BUPRENORPHINE HYDROCHLORIDE, USP; CODEINE PHOSPHATE; HYDROCODONE BITARTRATE DRUG SUBSTANCE.

API / Drug Master Files

NORAMCO INC holds 27 active (41 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• NALOXONE HYDROCHLORIDE (PROCESS II)Active2026-01-16
• NOROXYMORPHONE (PROCESS II)Active2025-07-03
• NOROXYMORPHONE (PROCESS I)Active2025-07-03
• LISDEXAETAMINE DIMESYLATE DRUG SUBSTANCEActive2021-11-23
• LEVORPHANOL TARTRATEActive2021-05-31
• BUPRENORPHINE HYDROCHLORIDE, USPActive2016-08-16
• BUPRENORPHINEActive2016-08-04
• MORPHINE SULFATE, USPActive2015-11-25
• NALOXONE HCl DIHYDRATE, USPActive2014-08-13
• METHYLPHENIDATE HCL USPActive2013-07-12
• METHYLNALTREXONE BROMIDEActive2012-09-14
• CODEINE PHOSPHATEActive2012-03-30
• NALOXONE HYDROCHLORIDE DRUG SUBSTANCEActive2011-02-15
• BUPRENORPHINE HYDROCHLORIDE (R036869) DRUG SUBSTANCEActive2010-04-05
• BUPRENORPHINE BASE (R371605) DRUG SUBSTANCEActive2010-04-05

Showing 15 of 41 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to NORAMCO INC in our records. PharmaTek screens the full directory against live FDA enforcement data.